Seizert Capital Partners LLC Buys New Shares in Option Care Health, Inc. $OPCH

Seizert Capital Partners LLC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 58,468 shares of the company’s stock, valued at approximately $1,899,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock valued at $146,947,000 after purchasing an additional 989,048 shares during the period. Durable Capital Partners LP acquired a new position in Option Care Health during the 1st quarter worth approximately $122,905,000. Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock worth $91,209,000 after acquiring an additional 99,574 shares in the last quarter. Jennison Associates LLC grew its stake in Option Care Health by 145.6% in the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after acquiring an additional 1,267,660 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Option Care Health during the first quarter valued at approximately $70,965,000. 98.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the subject of several research reports. Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research report on Friday, October 31st. Cowen began coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. TD Cowen decreased their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research report on Monday, November 3rd. Citizens Jmp lowered their target price on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a report on Friday, October 31st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Option Care Health in a research note on Thursday, November 13th. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $35.67.

Insiders Place Their Bets

In other Option Care Health news, Director Norman L. Wright bought 3,411 shares of the business’s stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director directly owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The stock was acquired at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders bought 61,411 shares of company stock valued at $1,637,416. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

NASDAQ OPCH opened at $28.28 on Wednesday. The company has a fifty day moving average price of $27.72 and a 200-day moving average price of $29.51. The firm has a market cap of $4.49 billion, a price-to-earnings ratio of 22.62, a PEG ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.